Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | ACP3 | P15309 | 1/20 | 0.33 |
| ▸ | PGK1 | P00558 | 2/20 | 0.33 |
| ▸ | PGK2 | P07205 | 2/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | MIF | P14174 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
| ▸ | GRK5 | P34947 | 1/20 | 0.30 |
| ▸ | CDK8 | P49336 | 1/20 | 0.30 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18242566 | 0.95 | HDAC1 (0.37) | TAAR1HDAC1HDAC8ACP3PGK1 | |
| SCHEMBL18241981 | 0.95 | TAAR1 (0.37) | TAAR1HDAC1HDAC8ACP3PGK1 | |
| SCHEMBL18242626 | 0.91 | HDAC1 (0.38) | TAAR1HDAC1HDAC8ACP3PGK1 | |
| SCHEMBL18242739 | 0.90 | TAAR1 (0.38) | TAAR1HDAC1HDAC8ACP3PGK1 | |
| SCHEMBL18242764 | 0.89 | TAAR1 (0.39) | TAAR1HDAC1HDAC8ACP3PGK1 | |
| SCHEMBL18244182 | 0.85 | TAAR1 (0.39) | TAAR1HDAC1HDAC8ACP3PGK1 | |
| SCHEMBL18244037 | 0.84 | TAAR1 (0.36) | TAAR1HDAC1HDAC8ACP3MIF | |
| SCHEMBL18242981 | 0.84 | HDAC1 (0.40) | TAAR1HDAC1HDAC8ACP3PGK1 | |
| SCHEMBL18242348 | 0.83 | ACP3 (0.37) | TAAR1ACP3PGK1PGK2HTR2B | |
| SCHEMBL18244154 | 0.82 | TAAR1 (0.41) | TAAR1HDAC1HDAC8ACP3PGK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-10-22 | — | — | US | disclosed |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | CBR1, HAO2, CBR3 | TAAR1 1102/4885HDAC1 3660/4885HDAC8 3395/4885 |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | CBR1, HAO2, CBR3 | TAAR1 1102/4885HDAC1 3660/4885HDAC8 3395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.